header_aequus_team.jpg

Board of Directors

Non-Executive Chair:

James A. Bianco, M.D.
Principal Founder, President and CEO, Cell Therapeutics, Inc.

Other Directors:

Jack W. Singer, M.D.
Founder, Director, and Chief Medical Officer, Cell Therapeutics, Inc.
Co-inventor of the Genetic Polymer™ technology

Fred W. Telling, Ph.D.
CTI Board Member and former Vice President of Corporate Policy and Strategic Management for Pfizer, Inc.

David Cosman, Ph.D.
Former Distinguished Fellow and Research Director for Amgen and
Vice President, Molecular Biology for Immunex Corporation

Stewart D. Chipman, Ph.D.
Executive Vice President and Chief Scientific Officer, Aequus

Carl J. March, Ph.D., MBA
President and Chief Executive Officer, Aequus

 

Executive Management

Carl J. March, Ph.D., MBA, President and Chief Executive Officer

Dr. March, a protein chemist by training, spent over 19 years in R&D at Immunex, most recently serving as Senior Vice President of Information Technology and Biochemical Sciences. In addition to co-managing the day-to-day discovery research effort at Immunex, he was directly responsible for the company's biochemical sciences group, which provided biochemistry, bioinformatics, protein chemistry, proteomics, and small molecule expertise to Immunex's cytokine biology research platform. Dr. March was also responsible for the corporate library and information technology at Immunex and helped guide the successful integration of the company's information systems with those at Amgen following its acquisition of Immunex in 2002. He has co-authored more than 80 peer-reviewed scientific papers and is a co-inventor on 30 U.S. and numerous foreign patents. Dr. March received his B.A. in Chemistry from Willamette University, his Ph.D. in Chemistry from Purdue University and his MSIS and MBA (with Honors) from the University of Washington Business School. He has served on numerous advisory boards for both non-profit and academic institutions.

Back to Top

 

Stewart D. Chipman, Ph.D., Executive Vice President and Chief Scientific Officer

Dr. Chipman, co-inventor of the Genetic Polymer™ technology and Vice President of Research at CTI, is a biotech executive with over 15 years of experience in building and leading scientific teams focused on the discovery and development of novel human therapeutics in the fields of inflammation, metabolic bone diseases, and cancer biology. As Director of Biomolecular Screening at Immunex and Associate Director, Research at Amgen, Dr. Chipman provided expertise in high-throughput screening robotics and synthetic chemistry for small molecule lead discovery. Prior to joining Immunex, he was Director of Biology at ArQule in Boston. Dr. Chipman received his B.S. in Biology at Boston University and Ph.D. in Biochemistry from the Boston University School of Medicine. Prior to pursuing his career in biotech, Dr. Chipman was an Associate Professor of Medicine at The Johns Hopkins University Medical School. He has co-authored more than 40 peer-reviewed scientific papers and is a co-inventor on seven U.S. and foreign patents.

Back to Top

CORPORATE FACT SHEET

This brief summary of Aequus BioPharma's origin, technology, market and development plans describes the company's potential impact on the development, manufacture and commercialization of novel and follow-on biopharmaceuticals 

DOWNLOAD (PDF) blue_arrow.gif